HPR155 The Use of Patient-Reported Outcomes for New Drugs Approval in Europe: A Review of European Public Assessment Reports From 2017 to 2021

Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1284
https://www.valueinhealthjournal.com/article/S1098-3015(22)03489-1/fulltext
Section Title :
Section Order : 10834
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03489-1&doi=10.1016/j.jval.2022.09.1284
HEOR Topics :
Tags :
Regions :